28% af de patienter, der fik Mirapexin, havde symptomer (42 ud af 151), sammenholdt med 51% af de patienter, der fik levodopa (76 ud a 150).
28% of the patients taking Mirapexin had symptoms (42 out of 151) compared with 51% of the patients taking levodopa (76 out of 150).